Patent · US Active

C5AR antagonists

US9126939B2 · kind B2 · utility

27Cited by
13References
4Claims
0Family size

Inventors

Key dates

Filing dateJun 24, 2011
Grant dateSep 8, 2015
Priority date
Expiry dateJun 24, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D413/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds are provided that are modulators of the C5a receptor. The compounds are substituted piperidines and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activation of C5a receptors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.